1. Home
  2. AIV vs PHAR Comparison

AIV vs PHAR Comparison

Compare AIV & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$5.94

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIV
PHAR
Founded
1975
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
AIV
PHAR
Price
$5.94
$17.68
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$38.00
AVG Volume (30 Days)
2.2M
26.2K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
47.17%
N/A
EPS Growth
N/A
N/A
EPS
1.72
0.00
Revenue
$210,889,000.00
$362,274,000.00
Revenue This Year
$6.96
$25.19
Revenue Next Year
N/A
$4.47
P/E Ratio
$3.85
$3,006.53
Revenue Growth
39.67
26.78
52 Week Low
$5.24
$7.50
52 Week High
$9.29
$18.30

Technical Indicators

Market Signals
Indicator
AIV
PHAR
Relative Strength Index (RSI) 59.65 51.55
Support Level $5.53 $16.55
Resistance Level $5.81 $18.30
Average True Range (ATR) 0.11 0.80
MACD 0.05 -0.07
Stochastic Oscillator 84.16 41.02

Price Performance

Historical Comparison
AIV
PHAR

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: